Cargando…
Future Perspective of Chemotherapy and Pharmacotherapy in Thymic Carcinoma
SIMPLE SUMMARY: Thymic carcinoma is a rare cancer, and its biology remains largely unknown. Although complete surgical resection is a standard treatment for thymic carcinoma, systemic chemotherapy is frequently administered in metastatic or recurrent cases. Given the rarity, therapeutic agents are o...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8533972/ https://www.ncbi.nlm.nih.gov/pubmed/34680386 http://dx.doi.org/10.3390/cancers13205239 |